Aktiv Pharma Group
Amir Genosar has an extensive work experience starting in 2000 with their role as President at Plan A Solutions Inc. Amir held this position until 2013. In 2005, Genosar founded Steadymed, where they served as a founder until 2010. In 2008, they founded Fluonic. Finally, in 2009, Genosar became the CEO and founder of AktiVax.
Amir Genosar attended the Technion - Israel Institute of Technology from 1993 to 1997. However, no specific degree or field of study information has been indicated.
Aktiv Pharma Group
Aktiv Pharma Group develops a novel rescue auto-injector device designed to solve problems in emergency treatments. The company's device allows people with minimal training to deliver and inject life-saving treatment to people with critical conditions in emergency conditions, thus providing patients at risk with enhanced lifesaving treatmentand methods of delivering medicine and drugs.